Dr. André T. Dahinden, General Manager of Amgen Switzerland, talks about their four cutting-edge products that will help drive future growth, reveals how being innovative includes partnering with payers for improved pricing models, and why the Swiss healthcare environment is like the Swiss railway system: well organized, punctual and reliable.
In July this year, Amgen released its second quarter results for 2016, with revenues increasing an impressive 6 percent versus the second quarter of 2015 to $5.7 billion. What particular products have been driving your growth in Switzerland?
"Switzerland is a small country, with a proportionally dense number of high quality institutes in Zurich, Basel and Geneva all quite close to each other, ensuring an easy sharing of knowhow and expertise between these institutes."
